Study of Apixaban in Patients Receiving Hemodiafiltration

NCT04952792 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

11

Enrollment

OTHER

Sponsor class

Conditions

Atrial Fibrillation
Hemodialysis Complication

Interventions

DRUG: Apixaban 2.5 milligram Oral Tablet

Sponsor

Hospital Universitari de Bellvitge

Collaborators

[object Object]
[object Object]